Could you provide some references to support your argument? Patent applications are not proper references.
Here are some to support mine.
With regard to the value of patents (and the dubious worth of patent applications), here's the Bioshares website. In particular, read 'Biotech checklist for investors.'
http://www.bioshares.com.au/investmentguide.htm
With regard to FDA.
The FDA classed APAS as Class II with special controls. On page 4, second last, of its Classicifation document, it says equivalent devices will need FDA clearance before marketing.
http://www.accessdata.fda.gov/cdrh_docs/pdf15/DEN150059.pdf
- Forums
- ASX - By Stock
- Why the hype?
Could you provide some references to support your argument?...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LBT (ASX) to my watchlist
|
|||||
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $23.30M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.5¢ | $8.549K | 565.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 250000 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 188838 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 250000 | 0.014 |
4 | 1273383 | 0.013 |
4 | 249166 | 0.012 |
3 | 123500 | 0.011 |
5 | 1150000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 188838 | 1 |
0.017 | 219797 | 3 |
0.018 | 600000 | 6 |
0.019 | 480000 | 1 |
0.020 | 200000 | 2 |
Last trade - 11.33am 09/07/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |